Panacea Biotec gains on wining Rs 83.52 vaccine order

The company has won an order for supply of Pentavalent Vaccine worth around Rs 83.52 crore by Pan American Health Organization (PAHO).

Panacea Biotec has gained over 6% to Rs 147 after being elected for the supply of Pentavalent Vaccine worth around Rs 83.52 crore by Pan American Health Organization (PAHO).

The Company has been awarded for supply of 5.99 Million doses of EasyFive-TT (DTP-HepB-Hib) fully liquid Pentavalent Vaccine for calendar year 2015 and 2016 worth USD 13.49 Million (equivalent to around Rs. 83.52 Crore) to meet the requirements of global immunization program.

The stock opened at Rs 140.15 and has hit a high of Rs 150.90 till 12:30 hrs while around 66,000 shares have changed hands on BSE and NSE combined.